Brief: Pharmaust Seeks Trading Halt
30/06/2023 01:31
June 30 (Reuters) - Pharmaust Ltd PAA.AX :
* PHARMAUST LTD - SEEKS TRADING HALT PENDING ANNOUNCEMENT ON
PHARMACODYNAMIC RESULTS FROM MOTOR NEURONE DISEASE PHASE 1/2
CLINICAL TRIAL
Source text for Eikon: ID:nASX7XmGRY
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility